MEM 1ML INJ
Rs 14.93 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
MEM 1ML INJ
MEM 0.2MG Injection contains Methylergometrine, an ergot alkaloid used in the routine management of uterine atony, hemorrhage, and subinvolution of the uterus following the delivery of the placenta. This medication is crucial in controlling uterine hemorrhage after childbirth by inducing sustained contractions of uterine muscles, thereby compressing blood vessels and reducing blood loss. Administered by healthcare professionals either intravenously or intramuscularly, it is not recommended for use during pregnancy and breastfeeding. Additionally, patients with high blood pressure, heart, liver, or kidney problems should exercise caution. Common side effects include hypertension, seizure, and headache. This injection is essential for managing postpartum complications effectively.
Product Highlights and Usage:
Active Ingredient: Methylergometrine 0.2 mg Usage: Used for managing uterine atony, hemorrhage, and subinvolution of the uterus post-delivery. Administration: Given intravenously or intramuscularly by healthcare professionals. Mechanism: Causes sustained uterine contractions, leading to reduced blood loss. Precautions: Not recommended for use in pregnancy and breastfeeding; caution in patients with high blood pressure, heart, liver, or kidney issues.
How it works:
MEM 0.2MG INJECTION works by directly stimulating sustained contractions of uterine smooth muscles. This action compresses blood vessels, thereby controlling or reducing blood loss after childbirth.
Directions for use:
MEM 0.2MG INJECTION will be administered by a doctor or nurse either as an intravenous (IV) or intramuscular (IM) injection. Your doctor will determine the appropriate dose and duration of treatment based on factors such as your age, body weight, and specific medical condition. It is important to follow your doctor's instructions carefully during the administration of MEM 0.2MG INJECTION.
Warning & Precaution:
PREGNANCY MEM 0.2MG INJECTION is generally not recommended for use during pregnancy. Consult your doctor before receiving MEM 0.2MG INJECTION if you are pregnant. BREASTFEEDING MEM 0.2MG INJECTION is generally not recommended for use in breastfeeding women as it may pass into breast milk. Consult your doctor before receiving MEM 0.2MG INJECTION if you are breastfeeding. KIDNEY MEM 0.2MG INJECTION should be used cautiously in patients with kidney problems, such as impaired renal function. Consult your doctor before receiving MEM 0.2MG INJECTION if you have kidney issues. LIVER: MEM 0.2MG INJECTION should be used cautiously in patients with liver problems, such as impaired hepatic function. Consult your doctor before receiving MEM 0.2MG INJECTION if you have liver issues. ALLERGY Do not receive MEM 0.2MG INJECTION if you are allergic to Methylergometrine or any other ingredients in the medication. HEART DISEASE MEM 0.2MG INJECTION should be used with caution in patients with heart problems, such as coronary artery disease. Consult your doctor before receiving MEM 0.2MG INJECTION if you have a heart condition.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$